SCHEMBL7102367

SCHEMBL7102367

CC(C)(C)OC(=O)NC(C(=O)NCc1ccccc1)C(=O)NCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.59
CTSK P43235 7/20 0.58
CTSS P25774 7/20 0.56
CTSB P07858 2/20 0.56
CTSL P07711 1/20 0.56
BACE1 P56817 4/20 0.55
CA12 O43570 2/20 0.53
CA1 P00915 2/20 0.53
CA7 P43166 2/20 0.53
CA14 Q9ULX7 2/20 0.53
CA2 P00918 1/20 0.50
CA3 P07451 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA5A P35218 1/20 0.50
CACNA1C Q13936 1/20 0.50
SCN9A Q15858 1/20 0.50
CA9 Q16790 1/20 0.50
CA13 Q8N1Q1 1/20 0.50
CA5B Q9Y2D0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23952926 0.90 ATM (0.52) ATMCTSKCTSSCTSBCTSL
SCHEMBL9582823 0.88 CTSS (0.62) ATMCTSKCTSSCTSBCTSL
SCHEMBL42634 0.88 CTSS (0.62) ATMCTSKCTSSCTSBCTSL
SCHEMBL30968897 0.88 CTSS (0.62) ATMCTSKCTSSCTSBCTSL
SCHEMBL13583903 0.88 CTSS (0.62) ATMCTSKCTSSCTSBCTSL
SCHEMBL2393583 0.87 BACE1 (0.59) ATMCTSKCTSSCTSBCTSL
SCHEMBL29253632 0.87 BACE1 (0.59) ATMCTSKCTSSCTSBCTSL
SCHEMBL30279569 0.87 BACE1 (0.59) ATMCTSKCTSSCTSBCTSL
SCHEMBL4057580 0.86 ATM (0.56) ATMCTSKCTSSCTSBCTSL
SCHEMBL4057582 0.86 ATM (0.56) ATMCTSKCTSSCTSBCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140818-B1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMA INC (US) 2003-09-10 EP disclosed
US-6329550-B1 FOR THERAPY OF EMPHYSEMA, OSTEOPOROSIS, RHEUMATOID ARTHRITIS AND NEOPLASTIC DISEASES AVENTIS PHARMACEUTICALS INC. 2001-12-11 US disclosed
EP-1140818-A1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE Aventis Pharmaceuticals Inc. (US) 2001-10-10 EP disclosed
WO-2000040552-A1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMACEUTICALS INC. (US) 2000-07-13 WO disclosed